Open Email...Your Power Lunch Trades Ideads Inside…
| | | | | | | Dear Reader, | | I hope you are having a great Wednesday! I am sending you the list of options signals for the next trading day (to help you cut your research in finding trading and/or investing opportunities). | 🤝 Partner with Elon Musk on Project Colossus… Before November 1st 🗓️ (ad)
Even though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks like you… To partner with Elon on what he believes will be the biggest AI project of the century… Starting with as little as $500.
👉 Click here to see how you could take a stake in Elon's private company. | | Stock Name | Signal Date | Signal Name |
|---|
| BRK-A | Oct 29 | Golden Crossover | | BRK-B | Oct 29 | Golden Crossover | | VZ | Oct 29 | Golden Crossover | | TXN | Oct 29 | Golden Crossover | | NOW | Oct 29 | Below 200-MA | | BKNG | Oct 29 | Below 200-MA | | BSK | Oct 29 | Below 200-MA | | SYK | Oct 29 | Below 200-MA | | PLTR | Oct 29 | Double Top | | UL | Oct 29 | Double Top | | CDNS | Oct 29 | Double Top | | DB | Oct 29 | Double Top | | SBUX | Oct 29 | Double Bottom | | KHC | Oct 29 | Double Bottom | | DOW | Oct 29 | Double Bottom | | KLAR | Oct 29 | Double Bottom | | Click Here to View Your Full Report |
| | | | | AI's Next Wave: 3 Small-Caps Showing Early Breakout Signals (ad)
The AI chip boom isn't slowing down — it's accelerating. After ARM Holdings (ARM) debuted near $51 and surged to become a key AI player, investors are scrambling for the next early-stage winners. At Fierce Analyst, we specialize in spotting momentum before the headlines hit — tracking volume spikes, institutional accumulation, and hidden catalysts driving real price action. Our analysts just finalized a new report featuring three small-cap tech plays showing the same early-stage strength we saw in ARM before its breakout. Timing is everything — and these setups are developing fast.
🚀 Get Your Free Report: 3 Small-Caps Poised to Ride the Next AI Wave | | How to use signals in your trading/investing strategies: | | Options Trading - if you are an Options trader, you can use the Ride-the-Wave strategy (to target multi-day price momentum following a company's trade signal) or the Price Reversal strategy (to target the reversal following signal generation). Please click on Ride-the-Wave Strategy to learn more about it. | | Stock Trading - If you're a swing stock trader/investor or portfolio manager, you may want to consider entering or exiting your positiosn based on a the signal generation. Please click on Volatility Crush Strategy to learn more about it. | "I'm risking my reputation on this" (ad)
"An apology to my crypto critics" If I'm right about what's coming, this could be the most important book you'll read this year
Claim your FREE copy of my controversial book before I change my mind. | | At Options Hero, we're really excited to help you trade more confidently. To that end, we're constantly developing new content to go alongside our platform insights, which will further our mission to help you become a better trader. | | To your trading success, | | Support Team | | Options Hero | | PS:Options Hero is morning newsletter, powered by StockEarnings proprietary technology. | | | | | | |
| | | (ad)* This message is a PAID ADVERTISEMENT for Avant Technologies (OTCQB: AVAI) from Interactive Offers. StockEarnings, Inc. has received a fixed fee of $4,000 from Interactive Offers for multiple Dedicated Email Sends, Newsletter Sponsorships and SMS Sends between Oct 29, 2025 and Nov 04, 2025. Other than the compensation received for this advertisement sent to subscribers, StockEarnings and its principals are not affiliated with either Avant Technologies (OTCQB: AVAI) or Interactive Offers. StockEarnings and its principals do not own any of the stocks mentioned in this email or in the article that this email links to. Neither StockEarnings nor its principals are FINRA-registered broker-dealers or investment advisers. The content of this email should not be taken as advice, an endorsement, or a recommendation from StockEarnings to buy or sell any security. StockEarnings has not evaluated the accuracy of any claims made in this advertisement. StockEarnings recommends that investors do their own independent research and consult with a qualified investment professional before buying or selling any security. Investing is inherently risky. Past-performance is not indicative of future results. Please see the disclaimer regarding Avant Technologies (OTCQB: AVAI) on Smallcapsdaily website for additional information about the relationship between Interactive Offers and Avant Technologies (OTCQB: AVAI). Options Hero is a subsidiary of StockEarnings, Inc (SE). SE is a research service not owned or managed by registered brokers and therefore this site does not make any investment recommendations. The information provided in this newsletter is not guaranteed as to the accuracy or completeness. Each user of SE chooses to do trades at their sole discretion and risk. SE is not responsible for gains/losses that may result in the trading of these securities. This newsletter includes paid advertisements. The source of all third-party content in which SE receives some sort of compensation, is clearly and prominently identified herein as "ad" or "Sponsored". Although we have sent you these advertisements, SE does not specifically endorse any third-party product nor is it responsible for the content of the advertisement or the experience with the third-party advertiser. Furthermore, we make no guarantee or warranty about what is advertised. All investments involve risk, losses may exceed the principal invested, and the past performance of a security, industry, sector, market, or financial product does not guarantee future results or returns. Please click here for SE Disclaimers. StockEarnings Inc 33 SE 4th St, Suite 100, Boca Raton, FL 33432 USA | W: 877.6.STOCKS | Unsubscribe
Today's Bonus Content: 🔥 From $5 to Headlines: Don't Miss the Next One
| | |
0 Response to "🎢 Your Options Alert for Oct 29 (Wednesday)"
Post a Comment